Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
BörsenkürzelMIR
Name des UnternehmensMirion Technologies Inc
IPO-datumJun 29, 2020
CEOLogan (Thomas D)
Anzahl der mitarbeiter2860
WertpapierartOrdinary Share
GeschäftsjahresendeJun 29
Addresse1218 Menlo Drive
StadtATLANTA
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl30318
Telefon17704322744
Websitehttps://www.mirion.com/
BörsenkürzelMIR
IPO-datumJun 29, 2020
CEOLogan (Thomas D)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten